Company Profile

Caerus Molecular Diagnostics Inc
Profile last edited on: 1/14/2021      CAGE: 5ZYT6      UEI: FP66RBHHNEE3

Business Identifier: Clinical sequencer for improved management of human diseases
Year Founded
2009
First Award
2010
Latest Award
2016
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

465 Fairchild Drive Suite 226
Mountain View, CA 94043
   (650) 248-9357
   info@caerusmdx.com
   www.caerusmdx.com
Location: Single
Congr. District: 16
County: Santa Clara

Public Profile

Caerus Molecular Diagnostics Inc is a DNA sequencing company developing an engineered enzyme switch as a “molecular amplifier” to convert the product of a single molecule DNA sequencing reaction into many copies of a reporter molecule that are easily detected. Amplification overcomes the accuracy limitations of existing single-molecule platforms, thereby enabling highly-parallel, low-cost, long read-length, high accuracy DNA sequencing on a scalable platform.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
10-14

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2016 2 NIH $765,147
Project Title: Enzyme Switch: Many Reporter Molecules from a Single-Molecule-Sequencing Product
2012 2 NIH $607,283
Project Title: Millikan Sequencing by Label-Free Detection of Nucleotide Incorporation

Key People / Management

  Javier Farinas -- President and Founder

  Andrea Chow -- Co-Founder, Former CFO and COO

  Roger Dettloff -- Former Director of Systems Engineering